Jennifer Macko

1.5k total citations
16 papers, 1.1k citations indexed

About

Jennifer Macko is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jennifer Macko has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Genetics. Recurrent topics in Jennifer Macko's work include Virus-based gene therapy research (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Research and Treatments (6 papers). Jennifer Macko is often cited by papers focused on Virus-based gene therapy research (7 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer Research and Treatments (6 papers). Jennifer Macko collaborates with scholars based in United States, Canada and Israel. Jennifer Macko's co-authors include Henrik Rasmussen, Farrell O. Mendelsohn, Paul Kessler, Robert J. Lederman, Emile R. Mohler, Jorge F. Saucedo, Corey K. Goldman, Brian H. Annex, Sanjay Rajagopalan and John Blebea and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Jennifer Macko

15 papers receiving 1.0k citations

Peers

Jennifer Macko
Young-Kwon Hong United States
J B Weiss United Kingdom
Shailen R. Patel United States
Kyung-Tae Kim South Korea
Sundeep Patel United States
Lisa P. Abramson United States
Kishor G. Lathi United States
Jennifer Macko
Citations per year, relative to Jennifer Macko Jennifer Macko (= 1×) peers Annica Pontén

Countries citing papers authored by Jennifer Macko

Since Specialization
Citations

This map shows the geographic impact of Jennifer Macko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Macko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Macko more than expected).

Fields of papers citing papers by Jennifer Macko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Macko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Macko. The network helps show where Jennifer Macko may publish in the future.

Co-authorship network of co-authors of Jennifer Macko

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Macko. A scholar is included among the top collaborators of Jennifer Macko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Macko. Jennifer Macko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Landers‐Ramos, Rian Q., Ryan M. Sapp, Jennifer Macko, et al.. (2016). Investigating the extremes of the continuum of paracrine functions in CD34/CD31+ CACs across diverse populations. American Journal of Physiology-Heart and Circulatory Physiology. 312(1). H162–H172. 11 indexed citations
2.
MacGill, Randall S., Thomas A. Davis, Jennifer Macko, et al.. (2007). Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response. Clinical & Experimental Metastasis. 24(7). 521–531. 24 indexed citations
3.
Stewart, Duncan J., Adrian Hilton, Jennifer M. Arnold, et al.. (2006). Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment. Gene Therapy. 13(21). 1503–1511. 194 indexed citations
4.
5.
Campochiaro, Peter A., Quan Dong Nguyen, Syed Mahmood Shah, et al.. (2006). Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial. Human Gene Therapy. 17(2). 167–176. 263 indexed citations
6.
Campochiaro, Peter A., Quan Dong Nguyen, Syed Mahmood Shah, et al.. (2006). Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial. Human Gene Therapy. 0(0). 2128726603–2128726603. 13 indexed citations
7.
Chang, Kenneth J., Neil Senzer, Stephen G. Swisher, et al.. (2006). Multi-Center Clinical Trial Using Endoscopy (END) and Endoscopic Ultrasound (EUS) Guided Fine Needle Injection (FNI) of Anti-Tumor Agent (TNFerade™) in Patients with Locally Advanced Esophageal Cancer. Gastrointestinal Endoscopy. 63(5). AB83–AB83. 11 indexed citations
8.
Farrell, James J., Neil Senzer, J. Randolph Hecht, et al.. (2006). Long-Term Data for Endoscopic Ultrasound (EUS) and Percutanous (PTA) Guided Intratumoral TNFerade Gene Delivery Combined with Chemoradiation in the Treatment of Locally Advanced Pancreatic Cancer (LAPC). Gastrointestinal Endoscopy. 63(5). AB93–AB93. 20 indexed citations
10.
Farrell, James J., Jennifer Macko, & J. Randolph Hecht. (2005). ENDOSCOPIC ULTRASOUND FINE NEEDLE INJECTION (EUS-FNI) OF A NOVEL GENE TRANSFER THERAPY AGAINST PANCREATIC CANCER: A SINGLE INSTITUTION EXPERIENCE. Pancreas. 31(4). 440–440. 3 indexed citations
11.
Chang, Kenneth J., Neil Senzer, J. Randolph Hecht, et al.. (2004). A Novel Gene Transfer Therapy Against Pancreatic Cancer (TNFerade) Delivered by Endoscopic Ultrasound (EUS) and Percutaneous Guided Fine Needle Injection (FNI). Gastrointestinal Endoscopy. 59(5). P92–P92. 25 indexed citations
12.
Senzer, Neil, Theodore D. Chung, J. Randolph Hecht, et al.. (2004). Safety and efficacy of TNFerade in unresectable, locally advanced pancreatic cancer (LAPC): Results of the first three cohorts of a dose-escalating study. Journal of Clinical Oncology. 22(14_suppl). 3038–3038. 3 indexed citations
13.
Fuchs, Shmuel, Nabil Dib, Barry M. Cohen, et al.. (2003). A randomized double blind placebo controlled multicenter pilot study of the safety and feasibility of AdGVVEGF121.10 via an intramyocardial injection catheter in patients with advanced coronary artery disease. Journal of the American College of Cardiology. 41(6). 21–21. 1 indexed citations
14.
Rajagopalan, Sanjay, Emile R. Mohler, Robert J. Lederman, et al.. (2003). Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease. Circulation. 108(16). 1933–1938. 435 indexed citations
15.
Rasmussen, Henrik, et al.. (2002). Angiogenic gene therapy strategies for the treatment of cardiovascular disease.. PubMed. 4(5). 476–81. 11 indexed citations
16.
Rasmussen, Henrik, Camilla Rasmussen, & Jennifer Macko. (2002). VEGF gene therapy for coronary artery disease and peripheral vascular disease. 3(2). 114–117. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026